Xinxiang Tuoxin Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 241.28 million compared to CNY 281.94 million a year ago. Revenue was CNY 246.65 million compared to CNY 284.03 million a year ago.

Net income was CNY 54.06 million compared to CNY 53.34 million a year ago. Basic earnings per share from continuing operations was CNY 0.43 compared to CNY 0.56 a year ago. Diluted earnings per share from continuing operations was CNY 0.43 compared to CNY 0.56 a year ago.